Preview

Rational Pharmacotherapy in Cardiology

Advanced search

CHARACTERISTICS OF THE TYPES OF LEFT VENTRICULAR REMODELING AMONG WORKING AGE MEN WITH ISCHEMIC HEART DISEASE, LIVING IN ONE OF THE MOUNTAIN REGIONS OF AZERBAIJAN

https://doi.org/10.20996/1819-6446-2013-9-1-44-47

Full Text:

Abstract

Aim. To evaluate the rate of left ventricular hypertrophy (LVH) and left ventricular (LV) geometry types in ischemic heart disease (IHD) among men of working age in one of the mountain regions of Azerbaijan.

Material and methods. A representative sample of the informal working age men population living in the foothills and midlands of theRepublic ofAzerbaijan was examined. Representative sample was formed by the method of random numbers. Strictly standardized survey methods and evaluation criteria recommended by WHO for epidemiological studies were used. Echocardiography with evaluation of the heart morphological parameters was performed in all the subjects.

Results. The prevalence of LVH in IHD patients was 68.8% [based on the calculation ofLV mass (LVM) and the LVM index (LVMI)]. The most reliable LVH detection was observed with calculation of three indexes LVMI, LVMI/height and LVM/height2,7. The least reliable LVH detection was observed with use only one index LVM/ height2,7. Normal LV geometry was registered in 20 (21.5%) patients with IHD,LV concentric remodeling in 18 (19.4%), concentric LVH in 23 (24.7%), and eccentric LVH in 32 (34.4%) patients.

Conclusion. The results of the study show significant prevalence of both LVH and adverse types ofLV remodeling in this population. This calls for further research to study the causes of revealed epidemiological situation.

About the Authors

N. R. Ismaylova
Azerbaijan State Institute of Postgraduate Medical Education named after A. Aliyev, Baku
Azerbaijan


F. A. Kuliev
Azerbaijan State Institute of Postgraduate Medical Education named after A. Aliyev, Baku
Azerbaijan


A. F. Zeynalov
Azerbaijan State Institute of Postgraduate Medical Education named after A. Aliyev, Baku
Azerbaijan


References

1. Devereux RB, Dahlof B, Gerdts E et al. Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol. Circulation 2004; 110: 1456–1462.

2. Brown DW, Giles WH, Croft JB. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension. Am Heart J 2000; 140: 848–856.

3. De Simone G., Kitzman DW., Chinali M. et al. Left ventricular concentric geometry is associated with impaired relaxation in hypertension: the HyperGEN study. Eur J Heart 2004; 30: 1–7.

4. Lorell BH, Carabello BA. Left ventricular hypertrophy. Pathogenesis, detection and prognosis. Circulation 2000;102: 470–479.

5. Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19(7): 1550–1558.

6. Baicu CF, Zile MR, Aurigemma GP, Gaasch WH. Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure. Circulation 2005; 111: 2306–2312.

7. Bonow RO, Mann DL, Zipes DP, Libby P. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 9th edition. Philadelphia: Elsevier Saunders; 2011.

8. Dzau V, Braunwald E. Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement. Am Heart J 1991;121(4 Pt 1): 1244–1263.

9. Dzau VJ, Antman EM, Black HR et al. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation 2006; 114(25): 2850–2870.

10. Podzolkov V.I, Bulatov V.A. Myocardium. Nephron. A look through the lens of evolution of hypertension. Russkiy Meditsinskiy Zhurnal 2008; 16(11): 1517–1523. Russian (Подзолков В.И, Булатов В.А. Миокард. Нефрон. Взгляд через призму эволюции артериальной гипертензии. Русский Медицинский Журнал 2008; 16(11): 1517–1523).

11. Dzau VJ, Antman EM, Black HR et al. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions. Circulation 2006;114(25):2871–91.

12. Jackson R., Wells S., Rodgers A. Will screening individuals at high risk of cardiovascular events deliver large benefits? Yes. BMJ 2008; 337: 1371.

13. Hellermann JP., Reeder GS., Jacobsen SJ et al. Longitudinal trends in the severity of acute myocardial infarction: a population study in Olmsted Country. Minnesota. Am J Epidemiol 2002; 156: 246–253.


For citation:


Ismaylova N.R., Kuliev F.A., Zeynalov A.F. CHARACTERISTICS OF THE TYPES OF LEFT VENTRICULAR REMODELING AMONG WORKING AGE MEN WITH ISCHEMIC HEART DISEASE, LIVING IN ONE OF THE MOUNTAIN REGIONS OF AZERBAIJAN. Rational Pharmacotherapy in Cardiology. 2013;9(1):44-47. (In Russ.) https://doi.org/10.20996/1819-6446-2013-9-1-44-47

Views: 352


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)